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Abstract
It is frequently accepted that grape seed proanthocyanidins (GSPs) are efficient antioxidants and beneficial in improving
cognitive functions. However, diabetes (T1DM)-associated declines in learning and memory and the possibilities of GSPs in
overcoming this loss needs to be examined. The present study was designed to examine the correlation, if one exists, between
cognitive behavior and neuronal survival in the prefrontal cortex (PFC) in streptozotocin (STZ)-induced diabetic Wistar rats as
well as to further clarify whether the correlation exists. Also this study aimed to determine whether neurological structural
changes in the PFC and pancreatic β-cells can be restored by grape seed proanthocyanidin extract (GSPE). At the end of 8 weeks,
cognitive tests that rats given supplementation of GSPE and insulin had greater improvement in their spatial learning andmemory
skills and improved neuronal survival in the PFC and pancreatic β-cells compared to rats supplemented with either insulin or
GSPE alone. Expression of Bax in the PFC was increased in the diabetic rats while Bcl-2 expression was decreased, and GSPE
and insulin treatment reversed the expression of apoptotic proteins. Our findings on GSPE, a natural product, as a form of
adjuvant therapy together with insulin treatment is suggestive of the existence of synergism between the two in attenuating
diabetic complications in the pancreas and PFC.
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Introduction
Diabetes mellitus is a common metabolic disorder, character-
ized by hyperglycemia and associated with chronic complica-
tions such as nephropathy, angiopathy, retinopathy and pe-
ripheral neuropathy. In type 1 diabetes mellitus (T1DM), in-
sulin production in the pancreatic islet cells is completely hin-
dered due to a decrease in the number of islet cells. Diabetes is
also associated with progressive end-organ damage in the cen-
tral nervous system (Brands et al. 2005) and this complication
referred to as “diabetic encephalopathy” is characterized by
impaired cognitive functions involving neuronal dysfunction
and neurochemical abnormalities. Neuropsychological studies
have shown that patients with T1DM perform worse than
patients without T1DM on several cognitive functions.
Although the extent of this varies, this poor cognitive perfor-
mance is inevitably noticed during childhood (Desrocher and
Rove 2004), and it encompasses deficits related to intelli-
gence, attention, processing speed, memory, and executive
skills (Kodl and Seaquist 2008; Perantie et al. 2007;
Northam et al. 2001 in addition to psychomotor abilities.
Eventually, the progression and storage of these deficits for
an extended period leads to dementia in diabetic patients
(Weinger et al. 2008; Ryan et al. 2003).
During these pathological changes, damaged mitochon-
dria develop imperfectly coupled electron transport sys-
tems and, becoming a primary source of reactive oxygen
species (ROS) in the cell. Therefore, oxidative stress (OS)
is widely accepted as a key mediatory process in the
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development and progression of diabetic complications,
due to an increased production of free radicals (FRs)
and impaired antioxidant defenses (Ceriello 2003).
Streptozotocin (STZ), a diabetes-inducer, is a powerful
alkylating agent that interferes with glucose transporters
and glucokinase function and induce double-strand DNA
breaks (Watala et al. 2009). Grape seed proanthocyanidin
extract (GSPE) is widely distributed in red grape seeds that
include (+) catechin, (−)epicatechin and gallic acid. GSPE
mitigates FRs and alleviates OS in the hippocampus (Asha
Devi et al. 2011) and cerebral cortex (Asha Devi et al.
2006) in aging rats. Proanthocyanidins play a key role in
glucose homeostasis, and the altered insulin production is
also related to number of insulin producing cells (Pinent
et al. 2004). GSPE is water-soluble and more easily crosses
the blood-brain barrier than many other antioxidants
(Ahmad 2013). Zhen et al. (2014) have reported that
GSPE can improve cognitive performance in rats that are
subjected to experimental seizures and exert an
antihyperglycemic effect in T1DM (Pinent et al. 2004).
Biochemical and structural changes in the diabetic brain
are caused by a chronically increased intracellular glucose
concentration (Mastrocola et al. 2005; Weigner and
Jacobson 1998) and changes in the cerebral cortex –depen-
dent neurocognitive functions (Stiles and Seaquist 2010).
However, studies related to ultra structural changes in the
prefrontal cortex (PFC) and β-cell destruction, which may
affect the cognitive outcomes in T1DM; this may be related
apoptotic factors that lead to neuronal death. Furthermore,
although studies related to natural products and cognitive
impairments in diabetes have been carried out, the effects
of GSPE supplementation and insulin treatment on the pan-
creas and PFC have not yet been studied extensively.
Thus, the present study on an observed animal model of
T1DM while addressing the effects of GSPE in an attempt to
evaluate the responses to GSPE diabetic brain has attempted
to evaluate the responses in terms of possible (i) improvement
in the cognitive ability of rats with STZ-induced diabetes (ii)
prevention of morphological alterations in the PFC and pan-
creas (iii) influence on Bcl-2 and Bax genes in the PFC (iv)
effectiveness of GSPE along with adjunct insulin treatment on
the aforesaid parameters.
Materials and methods
Animals
All procedures involving animals were approved by the
Institutional Animal Ethics Committee (IAEC) of Bangalore
University(Bangalore, India) and complied with the guide-
lines of the Control for the Purpose and Supervision of
Experiments on Animals (CPCSEA).
Adult male Wistar rats (150–170 g) were used for the
study. Three to four rats were kept in polyethylene cages
and exposed to a 12 h light/dark cycle and with free ac-
cess to standard food pellet (Amruth Feeds, Bengaluru),
and water ad libitum.
Materials
STZ (SO130-100MG) was procured from Sigma-Aldrich,
St. Louis, MO, USA. GSPE(trade name: Gravinol, GVSE
16013, 99% Purity) was obtained from Kikkoman Co. Ltd.;
Noda, Japan. Gravinol is an extract from grape seeds with
water and ethanol as eluents which has been concentrated
followed by concentration. It contains proanthocyanidin
and other components. The insulin used in this study was
obtained from Novo Nordisk, India. All other chemicals
were of reagent or analytical grade.
Experimental design
A total of 72 animals were divided randomly into four sub-
groups. Animals were categorized into six groups as follows:
(1) control rats (CON); (2) control rats treated with GSPE
(CON+PA); (3) STZ-induced diabetic rats (STZ); (4) diabetic
rats treated with GSPE (STZ + PA); (5) diabetic rats treated
with insulin (STZ + INS); and (6) diabetic rats treated with
insulin and GSPE(STZ + INS + PA).
Induction of diabetes
STZ was dissolved in a 0.1 M citrate buffer (pH 4.5) and
injected intraperitoneally with a single dose of 60 mg/kg
of body weight following overnight fasting according to a
previous data (Furman 2015; Fan et al. 2012). Diabetes
was confirmed after 3 days of injection for beta-cell dam-
age by measuring blood glucose using a glucometer
(Accu-check Active) wherein the glycemic index was
higher than 200–210 mg/dl.
The control group was given a buffer (vehicle), while the
GSPE- supplemented animals were administered GSPE orally
at a daily dose of 75 mg/kg body weight. STZ + INS and
STZ + INS + PA groups were treated with insulin with a daily
dose of 3 U over a period of 60 days.
Body weight and food intake were recorded weekly
along with blood sugar (glucose). An oral glucose toler-
ance test (OGTT) was performed at 1 and 16 weeks fol-
lowing the induction of diabetes. Rats were fasted over-
night and a glucose solution of 200 g/L was orally admin-
istered at a dose of 2 g/kg body weight. Blood glucose
was measured at 0, 30, 60 and 120 min after fasting by
the method described by Ding et al. (2013).
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Evaluation of spatial working memory
After the confirmation of diabetes, animals (n = 11 per sub-
group) were subjected to the T-maze in order to assess their
learning performance and working memory retrieval. Win-
shift strategy i.e. delayed no-match to sample (Morellini
2013) of spatial left-right discrimination tasks were employed
in the T-maze (Deacon and Rawlins 2006) in this study.
The rats were first habituated in the T-maze in two
phases. During the first phase (day 1, exploration), rats
were allowed to explore the maze for four 5 min-trials
with a given inter-trial interval (ITI) of 10 min. During
each trial both arms were baited with feed as a reward. In
the second phase (Days 2 and 3, habituation proper), each
rat performed 10 trials with a spatial alteration delay
(SAD) of 60 s in a pseudo-random sequence. During the
acquisition phase (from day 4 onwards) rats were trained
in accordance with the win-shift strategy. For the first trial
during acquisition both arms of the maze were baited and
rats received a reward by visiting either of them.
Thereafter, rats were trained to avoid the previously visit-
ed arm to get the reward. Each rat had to complete the
task within 120 s. After each trial, the maze was wiped
with 70% ethanol to remove clues from previous trials.
After 14 days of acquisition, the rats were subjected to a
memory retention test. The memory retention tests were
scheduled once a week for 4 weeks with 60 s SAD and 10
trials per rat; for this, rats had to complete the task within
60 s. Scoring was done manually and winning the reward
was considered to indicate a correct choice. The olfactory
trails between inter trials were removed by cleaning the
surface of the T-Maze with 70% alcohol.
Memory
Memory was tested for rat’s working and reference memory at
intervals of one week over a period of 4 weeks through left-
and right-discrimination learnt tasks as described earlier
(Abhijit et al. 2017).
Isolation of brain regions
Following the completion of neurobehavioral studies, rats
were subjected to CO2 asphyxiation; their brains were re-
moved quickly, washed in a 0.9% ice-cold saline and
placed in cold phosphate buffer (0.1 M) prior to microdis-
section. The PFC was dissected from the brain between
bregma 4.68 to 2.52 mm. Isolated tissue from each group
were weighed and fixed overnight in a 3% buffered glutar-
aldehyde (pH 7.2) for 24 h for electron microscopic stud-
ies. For light microscopic studies, tissues were fixed in a
10% neutral buffered formalin and remaining tissue was
stored at -80 °C until the analyses was performed. For gene
expression studies, tissues were snap frozen in liquid nitro-
gen and stored at -80 °C for extraction of RNA.
Morphological studies
Light microscopy
Hematoxylin and eosin staining
Paraffin sections of 5 μm in thickness were deparaffinized in
xylene and rehydrated through grades of ethanol by the meth-
od described by Pearse (1961). Sections were stained with
hematoxylin, differentiated in 1% acid alcohol, blued in
0.2% ammonia water and rinsed in 95% alcohol. Sections
were counterstained with eosin, dehydrated through graded
ethanol series, cleared in xylene and mounted in DPX.
Nissl staining and neuronal quantification
Prefrontal sections of 5μm in thickness were deparaffinized in
xylene and hydrated in graded series of alcohol. Sections were
further stained in 0.1% cresyl violet, dehydrated in 70% eth-
anol to 100% ethanol, cleared in xylene and mounted in DPX.
Neuronal quantification was performed as described by
Pamidi and Nayak (2014). The number of surviving neurons
with their well-defined nuclei was counted while those with
shrunken perikaryon and disintegrated nuclei were
disqualified from quantification.
Electron microscopy
PFCs and pancreases were fixed in 3% buffered glutaraldehyde
(pH 7.2) for 24 h and washed in 0.1M phosphate buffer follow-
ed by post-fixation in 1% osmium tetroxide for 60 mino,
dehydrated in graded series of distilled alcohol, cleared in pro-
pylene oxide and impregnated in 1:1 ratio of propylene
oxide:Araldite resin overnight, then increased to 1:3 ratio
followed by pure araldite resin for 2–3 h. Later tissues were
embedded in flat embedding mould and kept in an oven at
60 °C for 48 h for polymerization (Palay and Chan-Palay 1974).
Ultramicrotomy: Tissue blocks were cut under UC6
Ultramicrotome (Leica Microsystems, Germany). Initially
1 μm thick sections were collected on a plane glass slide,
stained using 1% toluidine blue and viewed under light mi-
croscope to find interested area to study light microscopic
features. Later 400–500 A0 thick ultrathin sections were col-
lected on copper grids, stained using uranyl acetate and lead
citrate as described by Frasca and Parks (1960). After proper
staining, the ultrathin sections were scanned under Tecnai G2
Spirit Bio-twin Transmission Electron Microscope (FEI,
Netherland) and representative areas were photographed using
Megaview III CCD camera.
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Immunohistochemistry
Pancreatic insulin immunohistochemistry (IHC) was per-
formed using a slightly modified version of the method de-
scribed by Bolkent et al. (2005) using a Histostain-Plus kit
(Invitrogen, California, USA. 85–9043).
Tissue sections of the pancreases were deparaffinized,
rehydrated, washed in PBS 3X, (5 min each). Endogenous
peroxidase activity was inhibited by incubating the sections
in a washing buffer (PBS (7):MeOH(2):0.3% H2O2(1). Non–
specific binding sites were blocked by incubating in a
blocking buffer for 30 min. The sections were incubated over-
night with diluted primary antibody (1:1000μg/ml) for insulin
(Sigma-Aldrich, Missouri, United States, 084 M4769). This
was followed by washing the slides 3X (5 min each) in PBS.
Sections were incubated with biotinylated secondary antibody
for 60 min at room temperature (RT). Sections then were
washed 3X (5min each) in PBS. Sections were incubated with
an enzyme conjugate for 10 min. The substrate, diaminoben-
zidine tetra hydrochloride (Vector Laboratories, Burlingame,
Canada. SK-4100), was added to distilled water for 5–10 min.
This substrate gives a brown color at immunoreactive sites.
The slides were lightly counterstained by hematoxylin to gain
a good morphological identification of cells, and dehydrated
by passing through ascending concentrations of alcohol and
cleared by xylene. Sections were cover slipped with perma-
nent mounting media, Vectamount (Vector Laboratories,
USA,H-5000). Quantification was done by using NIH-
Image J Fiji software and expressed as units.
Plasma insulin level
Fasting (8 h) and fed (2 h after having a meal) circulating
insulin levels were determined by a commercial insulin
ELISA kit (Rat insulin ELISA kit, Thermo Scientific,
MA, USA, ERINS).
In brief, blood samples were collected from the abdominal
aorta. Plasma was separated immediately from blood samples
by centrifugation (3900 rpm for 20 min at 4o C). 100 μl of
each standard or sample was added to 96 wells and incubated
for 2.5 h at RT with gentle shaking. Then, the solutions were
discarded and washed four times with wash buffer. A volume
of 100 μl of biotinylated antibody was added to each well and
incubated for 1 h and washed four times with a wash buffer. A
volume of 100 μl of streptavidin-HRP was added to each well
and incubated for 45 min at RTwith gentle shaking. Avolume
of 100 μl of TMB substrate was added to each well and incu-
bated for 30 min at RT in the dark with gentle shaking.
Reactions were stopped by the addition of 50 μl of a stop
solution to eachwell. The plate was evaluated in a micro- plate
reader (Infinite 200 PRO, TECAN Austria GMBH) at
450 nm. A standard curve was generated by plotting the
average absorbance obtained for each standard concentration
along the vertical y- axis and the corresponding insulin con-
centration along the x- axis. The amount of insulin in each
sample was determined by interpolating from the y-axis value.
Sample absorbance values were multiplied by dilution factor.
Evaluation of Bcl-2 and Bax gene expression
studies in prefrontal cortex
RNA isolation
Tissue samples (100 mg) were homogenized with Teflon
pezzle. Total RNA was isolated using the TRIzol Reagent
method (Life Technologies) according to the manufacturer’s
instructions. cDNAwas synthesized from 2 μg of RNA using
the Verso cDNA synthesis kit (Thermo Fischer Scientific AB-
1453/A) with an oligo dT primer according to the manufac-
turer’s instructions. The reaction volume was set to 20 μl and
cDNA synthesis was performed at 42o C for 60 min, followed
by reverse-transcriptase inactivation at 85o C for 5 min.
Primers were obtained from Euro fins Genomics, India.
Real-time semiquantitative polymerase chain
reaction
A semi-quantitative reverse-transcriptase polymerase chain
reaction (RT-PCR) was carried out using Techno Prime sys-
tem to determine the levels of Bcl-2, Bax and β-actin mRNA
expressions. The RT-PCR mixture (final volume 20 μL)
contained 1 μL of cDNA, 10 μL of Red Taq Master Mix 2×
(Amplicon) and 1 μM of each complementary primer specific
for Bcl-2, Bax and β-actin (internal control) sequences
(Table 1). The samples were denatured at 94o C for 5 min,
and amplified using 30 cycles of 94o C for 30 s, 55o C for 30 s,
and 72o C for 1 min for Bcl-2, Bax andβ-actin genes followed
by a final elongation at 72o C for 10 min. The optimal num-
bers of cycles were selected for amplification of all three genes
experimentally so that amplifications were in the exponential
range and did not reach a plateau. Ten μL of the final ampli-
fication product were run on a 2% ethidium-stained agarose
gel and photographed. Quantification of the results was ac-
complished by measuring the optical density of the bands,
using the computerized imaging program Image J. The values
were normalized to β-actin intensity levels.
Statistical analyses
Data analysis was performed using GraphPad Prism 6.7
software and reported as mean ± SEM. The data was fur-
ther statistically compared using a one-way analysis of
variance (ANOVA) with Duncan’s multiple comparison
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post-hoc test. Different significance statuses were
assigned to groups and when compared with between
groups, are represented in lower case.
Results
Body weight
A two-way ANOVA revealed diabetic condition as a sig-
nificant factor for the weekly reduction in body weight (F
(5, 35) =122.7, P < 0.001). There was a significant reduc-
tion (p < 0.05) in body weight at the end of 4 weeks
(30.8%) and 8 weeks (48.4%) in rats in the diabetic group
with respect to normal control rats. However, the extent of
reduction was lesser in diabetic rats that were supplement-
ed with GSPE at the end of 4 weeks (8.46%) and 8 weeks
(11.82%). In the insulin-treated diabetic rats, the reduction
in body weight was by 1.23 and 3.7% at the end of
4 weeks and 8 weeks respectively of STZ administration.
In the GSPE supplemented and insulin treated diabetic
rats, there was insignificant reduction in body weight at
both 4 weeks and 8 weeks (Table 2).
Blood glucose
Fasting blood sugar (FBS)
The FBS levels of diabetic rats were significantly higher
(172.6%, p < 0.05) than those of controls 2 weeks fol-
lowing administration of STZ. At 4 and 8 weeks, blood
glucose increased by 183 and 203% (p < 0.05) with re-
spect to the controls. GSPE administration to diabetics
increased the glucose level to a lesser extent at 8 weeks
and had increased by 167% with a further reduction in
the extent of increase by 146% compared to control rats
(Table 3). A similar trend was seen in insulin-treated
diabetic rats at 4 and 8 weeks following the induction
of diabetes. However, there was insignificant change in
glucose levels between GSPE-supplemented diabetic and
unsupplemented control rats.
Post prandial blood sugar (PPBS)
PPBS in the diabetics showed significant increases of 183 and
200% (p < 0.05) compared to control rats at 4 and 8 weeks of
diabetes induction. The extent of the increases in glucose was
reduced by 183 and 160.5% at 4 and 8 weeks in animals sup-
plemented with GSPE. Insulin-treated diabetic rats, however,
exhibited lesser extent of glucose elevation and were by 160
and 153% higher than controls at 4 and 8 weeks after diabetes
induction. GSPE supplementation combined with insulin treat-
ment to diabetic animals resulted in the lowest elevation in
glucose at 4 weeks (155.7%) and 8 weeks (148%) (Table 3).
Overall, the extent of increases in blood glucose, FBS, and
PPBS, in the diabetics is summarized as: (STZ + PA) > (STZ +
INS) > (STZ + PA+ INS) which is suggestive of a synergistic
effect of GSPE and insulin in suppressing the elevation of glu-
cose levels in diabetic animals through the 8- week treatment of
insulin and oral supplementation of GSPE.
Oral glucose tolerance test
Table S1 shows the glucose tolerance of the control and exper-
imental groups at week 1(F (5,15) = 4.254, p < 0.001) and at
week 8(F (5,15) = 5.547, p < 0.001). Diabetic rats exhibited
significantly (p < 0.05) higher values compared to control rats
in the tests at 1 week and 8 weeks. GSPE- supplemented dia-
betic rats presented significantly (p < 0.05) lower glucose levels
at the two test periods with respect to the unsupplemented dia-
betic rats. A similar trend of reduced glucose levels in the
insulin-treated rats was seen with respect to the untreated dia-
betic rats. A combination of GSPE and insulin resulted in the
lowest glucose levels compared to either GSPE or insulin alone.
Food intake
Mean food intake between the controls and experimental
groups throughout the study showed significant differences
(F (5, 35) = 6.083, P< 0.001).
Diabetic rats showed higher food intake compared to the con-
trol rats. However, GSPE-supplemented and insulin-treated dia-
betic rats presented lower food intake with respect to untreated
Table 1 Sequence of primers for Bcl-2, Bax and β-actin
a Primer pair Sequence (5′→ 3′) Length Tm GC % Product size (bp)
Bcl-2 FP CTGGTGGACAACATCGCTCTG 21 61.8 57.1 228
RP GGTCTGCTGACCTCACTTGTG 21 61.8 57.1
Bax FP GACACCTGAGCTGACCTTGG 20 61.4 60 310
RP GAGGAAGTCCAGTGTCCAGC 20 61.4 60
β-actin FP TCCTCCTGAGCGCAAGTACTCT 22 62.1 54.5 153
RP GCTCAGTAACAGTCCGCCTAGAA 23 62.4 52.2
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diabetic rats. Food intake was significantly reduced in insulin-
treated and GSPE-supplemented rats with respect to diabetic rats
and compared to single treatments as shown in Table S2.
Behavioral studies
Assessment of changes in learning
Further, in order to examine the possible effect of GSPE and
insulin treatment in the animal’s cognitive ability, learning and
memory tests were conducted in a T-maze.
The two-way ANOVA revealed significant differences
between the control and experimental groups on day 4
(F(5,36) = 35.73, P < 0.001) and day 8 (F(5,36) = 63.14,
p < 0.001). Percent acquisition in the T-maze is repre-
sented in Fig. 1. As shown in Fig. 1a, on day 4, control
rats showed 45% correct choices while supplemented
controls displayed 54% correct choices. Diabetic rats
made only 27% correct choices; this increased to 38%
when supplemented with GSPE (p < 0.0001). Diabetic
rats with insulin -treatment displayed the same extent
of correct choices (P < 0.001) as that of their untreated
counterparts. Moreover, even more correct choices
Table 3 Blood sugar in response to GSPE and insulin treatment in streptozotocin-induced diabetic rats
Week CON CON+PA STZ STZ + PA STZ + INS STZ + INS +
PA
FBS
FBS (mg/dl)
2 92.5 ± 7.6a 92.0 ± 7.2a 252.2 ± 16.0bc 249.0 ± 10.1bc 248.2 ± 6.7bc 245.7 ± 6.1b
4 92.5 ± 7.0a 94.0 ± 6.5a 262.2 ± 15.2bc 247.7 ± 16.9b 243.7 ± 11.9b 236.0 ± 4.7b
6 94.0 ± 8.0a 93.0 ± 8.9a 278.0 ± 6.6b 241.0 ± 8.5c 240.5 ± 11.6c 230.7 ± 8.5c
8 94.5 ± 9.1a 94.0 ± 6.1a 287.0 ± 8.8b 233.0 ± 9.1c 230.0 ± 6.3c 227.0 ± 5.9c
10 91.7 ± 7.8a 94.5 ± 9.7a 295.2 ± 6.9b 228.7 ± 6.1c 226.2 ± 12.2c 220.0 ± 11.5c
PPBS (mg/dl)
2 126.75 ± 9.29a 123.7 ± 7.6a 343.5 ± 9.9bc 338.7 ± 12.9b 335.2 ± 10.3bc 332.0 ± 9.3bc
4 125.5 ± 8.2a 124.0 ± 6.5a 355.7 ± 11.1b 335.7 ± 7.2bc 326.0 ± 10.5bc 321.0 ± 6.2c
6 122.5 ± 8.4a 121.7 ± 7.7a 365.7 ± 7.4b 330.0 ± 5.8dc 320.0 ± 8.7dc 317.2 ± 12.7c
8 125.5 ± 5.3a 124.0 ± 13.0a 376.2 ± 9.3e 327.0 ± 5.2bc 318.2 ± 6.7bc 312.0 ± 8.1c
10 122.2 ± 8.4a 123.2 ± 5.3a 418.0 ± 9.1e 321.2 ± 8.77bc 308.7 ± 6.4bc 300.5 ± 8.8c
CON, control; CON+PA, GSPE supplemented control; STZ, STZ-induced diabetics; STZ+PA GSPE supplemented diabetics; STZ + INS, diabetics
treated with insulin; STZ + INS + PA, diabetics treated with INS and GSPE. GSPE, grape seed proanthocyanidin extract. Values are mean ± SEM (n = 7).
Significance was calculated by two-way ANOVA using GraphPad Prism 6 followed by Bonferroni comparison test. Groups sharing dissimilar lower
case are significant at p < 0.05
Table 2 Body weight in response to GSPE and insulin treatment in streptozotocin-induced diabetic rats
Body weights (gm)
Week CON CON+PA STZ STZ + PA STZ + INS STZ + INS +
PA
1 161.6 ± 2.3ad 166.4 ± 1.6ad 148.3 ± 2.6b 149.1 ± 3.0b 159.6 ± 3.3d 160.1 ± 1.5ad
2 164. 1 ± 4.2ad 172.5 ± 3.0a 140.4 ± 2.3b 152.7 ± 2.5c 161.0 ± 3.4d 162.1 ± 2.6d
3 171.9 ± 2.1ad 180.0 ± 2.3a 135.6 ± 1.4b 159.4 ± 3.5c 169.3 ± 2.3d 171.5 ± 3.2d
4 184.3 ± 1.6ad 187.7 ± 3.3a 127.4 ± 1.3b 168.7 ± 1.6c 171.8 ± 2.6d 174.3 ± 2.7d
5 188.1 ± 1.4a 192.1 ± 1.5a 120.5 ± 1.1b 165.4 ± 1.1c 176.5 ± 1.5da 182.4 ± 1.9ad
6 192.4 ± 1.5a 198.7 ± 2.0a 114.8 ± 1.1b 170.8 ± 2.3c 180.8 ± 1.7d 187.3 ± 1.6ad
7 203.7 ± 1.2a 210.6 ± 1.2a 110.0 ± 1.0b 174.8 ± 2.8c 189.4 ± 1.5d 196.8 ± 2.8ad
8 210.6 ± 1.3ad 220.8 ± 2.1a 108.7 ± 1.4b 185.7 ± 2.5c 202.8 ± 1.6d 208.4 ± 1.2d
CON, control; CON+PA, GSPE supplemented control; STZ, STZ-induced diabetics; STZ+PA, GSPE supplemented diabetics; STZ + INS, diabetics
treated with insulin; STZ + INS + PA, diabetics treated with INS and GSPE. GSPE, grape seed proanthocyanidin extract. Values are mean ± SEM (n = 7).
Significance was calculated by two-way ANOVA using GraphPad Prism 6 followed by Bonferroni comparison test. Groups sharing dissimilar lower
case are significant at p < 0.05
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(40%)(P < 0.001) were made with a combined-insulin
treatment and GSPE supplementation.
On day 8 (Fig. 1b), acquisition was improved in the control
rats, showing 60% correct choices while diabetics showed
only a slight improvement (38%). However, GSPE-treated
and insulin-treated diabetic rats made 48 and 58% correct
choices (P < 0.05) respectively while insulin treatment com-
bined with GSPE supplementation resulted in rats making
58% correct choice (P < 0.05).
Memory
GSPE and insulin treatment either singly or in combination
in diabetic rats showed significantly improved memory in
terms of correct choice during the memory test in the second
week (F (5, 36) = 52.33 P < 0.001) and fourth week (F (5,
36) = 36.61, P < 0.001) (Fig. 1c, d). STZ-induced diabetic
rats showed significantly reduced memory retrieval com-
pared to the non-diabetics when tested 2 weeks after the last
learning session. GSPE-supplemented rats improved their
memory retention to a similar extent as insulin- treated ones,
as shown in Fig. 1c.
At week 4, memory retention was lowered in all groups com-
pared to those that were tested inweek 2 (Fig. 1d). Compared to
the untreated diabetic animals, GSPE-supplemented and insulin-
treated animals showed an almost equal extent of improvement
in memory retention. A combination of INS and GSPE resulted
in an improvement in memory retention, but this was lower
compared to that seen during the second week.
Morphology of pancreas and prefrontal
cortex
Following the behavior tests, anatomical changes in the PFC,
region involved in cognitive skills were studied along with
insulin-secreting β-cells.
Pancreas
Light microscopy
Figure 2 displays photomicrographs of pancreatic tissue
stained with H & E. There was a reduction in the num-
ber of islets in the diabetic animals compared to the
controls, and diabetics supplemented with GSPE showed
improvements in this variable. Pancreatic tissues from
normal non-diabetic rats and those supplemented with
GSPE showed regular islets with clustered beta cells lo-
cated centrally (Fig. 2a). In the diabetic rats, islets
Fig. 1 Effects of GSPE and
insulin on cognitive behaviors in
a T-maze in diabetic rats.
Acquisition is represented in
terms of % correct choice at
4 days (a) and 8 days (b) of
learning and at 2- (c) and 4-(d)
weeks of spatial working memory
tests. CON, control; CON(PA),
GSPE-supplemented control;
STZ, STZ-induced diabetics;
STZ+(PA), GSPE-supplemented
diabetics; STZ + INS, diabetics-
treated with insulin; STZ + INS +
GSPE, diabetics treated with
insulin and GSPE. GSPE, grape
seed proanthocyanidin extract.
Values are mean ± SEM of 7
rats/group. Values are mean ±
SEM (n = 7 rats/group).
Significance was tested by
Tukey’s Multiple Comparison
Test and is represented in lower
case. Groups sharing different
letters are significant (p < 0.05)
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showed disintegrated β-cells (Fig. 2c) while GSPE re-
stored the normal morphology of β-cells (Fig. 2d).
Pancreatic sections from insulin-treated diabetic animals
had near- normal appearance of islets (Fig. 2e). However,
a combination of GSPE and insulin was more effective
in restoring the normal structure of pancreases in the
diabetic animals (Fig. 2f).
Ultrastructure of pancreas
The pancreases from control and GSPE-supplemented rats
showed normal morphology (Fig. 3a, b) with normal mito-
chondria and ER and a large number of secretory granules in
the β-cells. In the diabetic rats, disrupted secretory granules
and ER dilation were seen (Fig. 3c). Secretory granules has
increased and normal mitochondria in the β-cell were noticed
in the GSPE-supplemented diabetic animals (Fig. 3d). In the
insulin-treated (Fig. 3e), and GSPE- supplemented and treated
with insulin treated (Fig. 3f) exhibited abundant secretory
granules, normal mitochondria and RER.
Prefrontal cortex
Light microscopy
Significant loss in the neuronal cell body was seen in diabetic
PFCs (Fig. 4c). However, GSPE supplemented rats showed
neurons with clear nuclei (Fig. 4d). Insulin improved the num-
ber of surviving neurons (Fig. 4e). However, diabetic rats with
insulin treatment and GSPE supplementation (Fig. 4f) showed
an even greater number of neurons with clear nuclei.
Ultrastructure
Mitochondria in the control rats (Fig. 5a) and those treated
with GSPE (Fig. 5b) were intact and compact with well de-
fined cristae and membranes. In contrast to these,
Fig. 2 Photomicrographs of rat
pancreatic tissue stained with
hematoxylin and eosin. a CON,
control; b CON+PA, GSPE
supplemented control; c STZ,
STZ-induced diabetics; d STZ+
PA, GSPE supplemented
diabetics; e STZ+INS, diabetics
treated with insulin; f STZ+INS+
PA, diabetics treated with INS and
GSPE. X 40, Scale bar = 5 μm
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mitochondria were irregular, enlarged, and vacuolated with
damaged cristae in the diabetic rats (Fig. 5c). GSPE supple-
mentation resulted in more intact mitochondria with regular
cristae compared to the diabetic ones (Fig. 5d). In the insulin-
treated diabetic rats, a lesser extent of mitochondrial damage
was evident (Fig. 5e). A combination of insulin treatment and
GSPE supplementation resulted in more normal mitochondria
and RER (Fig. 5f).
Neuronal quantification
Two-way ANOVA revealed significant differences in neuro-
nal survival in the PFC between the control and experimental
groups at week 1[F(5,30) = 31.31, P< 0.001]. Figure 6 shows
neuronal quantification wherein the number of surviving neu-
rons was significantly reduced in the diabetic group compared
to the control group, while GSPE improved the number of
surviving neurons. A daily dose of insulin and GSPE re-
sulted in better survivability of the neurons compared to
either of them alone.
Pancreatic insulin immunoreactivity
Figure 7 represents photomicrographs of insulin immuno-
reactivity in the pancreatic islets. In the control group
(Figs. 7a and 8a) and GSPE-treated control animals, islets
displayed normal β cells (Figs. 7b and 8a) while in the
diabetic (Figs. 7c and 8a), the number of cells displaying
insulin immunoreactivity was lower than in rats supple-
mented with GSPE (Figs. 7d and 8a). However, daily
insulin treatments and GSPE supplementation resulted in
levels almost similar to the controls (Figs. 7f and 8a).
Fig. 3 Electron micrographs of
pancreatic β-cells stained with
uranyl acetate-lead citrate in. a
CON, control; bCON+PA, GSPE
supplemented control; c STZ,
STZ-induced diabetics; d STZ+
PA, GSPE supplemented
diabetics; e STZ+INS, diabetics
treated with insulin; f STZ+INS+
PA, diabetics treated with INS and
GSPE. X 23000 (Original
magnification)
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The one-way ANOVA showed significant effects of treat-
ments (F(5,12) = 41.61, P < 0.0001) on the insulin immuno-
reactivity of the pancreas. Immunoreactivity of the islets was
low in the diabetics compared to the controls while GSPE
supplementation resulted in improved reactivity. In the pan-
creatic islets of GSPE- supplemented and insulin- treated dia-
betics, the immunoreactive of β cells was increased compared
with either insulin or GSPE alone (Fig. 8a).
Plasma insulin
The one-way ANOVA revealed significant differences be-
tween the treatments on the fasting (F(5,12) = 33.62, P <
0.001) and post-prandial (F(5,12) = 33.62, P < 0.001) in-
sulin levels. In the diabetic rats, plasma insulin was re-
duced significantly (Fig. 8b, c) while these levels im-
proved in the GSPE-supplemented diabetics. Insulin treat-
ment alone or insulin treatment in combination with GSPE
supplementation was more effective in rising insulin levels
with respect to the diabetic animals. Interestingly, the plas-
ma insulin levels when checked at 8 weeks following STZ
administration could be related to the high glucose toler-
ance of the diabetics.
Evaluation of Bcl-2 and Bax expression
in prefrontal cortex
In order to study whether the observed deficits in cognitive
skills and decreased neuronal survival in the PFC is related to
pro-and anti-apoptotic gene expressions, a set of diabetic and
treated rats were tested for Bcl-2 and Bax expressions.
The level of Bcl-2 expressed in the PFC of diabetic rats
was significantly lower compared with control group
(Fig. 9a, lane 4). However, GSPE treatment increased
Bcl-2 expression (Fig. 9a, lane 4). Compared to the con-
trol group, Bax expressions were increased in the diabetic
Fig. 4 Microphotographs of rat
prefrontal cortex stained with
cresyl violet for Nissl substance. a
CON, control; bCON+PA, GSPE
supplemented control; c STZ,
STZ-induced diabetics; d STZ+
PA, GSPE supplemented
diabetics; e STZ+INS, diabetics
treated with insulin; f STZ+INS+
PA, diabetics treated with INS and
GSPE. X 40
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group (Fig. 9b, lane 3). Interestingly, GSPE was shown to
increase Bcl-2 (Fig. 9a, lane 4) and simultaneously de-
crease Bax (Fig. 9b, lane 4) expressions in the diabetic
group. The level of expression of Bcl-2 in insulin-treated
(Fig. 9a, lane 5) diabetic rats was higher than in the un-
treated rats (Fig. 9a, lane 3). The level of Bax expression
was lower in the insulin-treated diabetic group (Fig. 9b,
lane 5). Interestingly, GSPE in combination with insulin-
treatment revealed a greater expression of Bcl-2(Fig. 9b,
lane 6) with negligible levels of Bax (Fig. 9b, lane 6).
Figure 10 shows the Bax/Bcl-2 ratio in the PFC. The
ratio was significantly elevated in the diabetic group
compared to the control group and all other experimental
groups. Further, GSPE and insulin-treated groups
showed significant decreases in the ratio compared to
the diabetic group, although the changes were insignifi-
cant between GSPE supplemented and insulin- treated
groups. The lowest ratio of pro-apoptotic and anti-
apoptotic protein expression were seen with a combined
insulin and GSPE treatment.
Correlation studies
The Pearson correlation test was performed to determine if
any correlation, exists between the Bax and Bcl-2 expression
and the expression of Bax and Bcl-2 individually with mem-
ory retention in the PFC of experimental groups following
GSPE and insulin treatments. Fig.S1 is a graphical represen-
tation of the above description. Fig.S1 (A) depicts negative
correlation between Bax and Bcl-2 (r =−0.7020). The exis-
tence of a positive correlation was seen between % memory
retention and fold expression of Bcl-2 at week 2 (r = +0.511)
and week 4 (r = + 0.500); these are depicted in Figs.S1 (B)
and (D) respectively. The occurrence of negative correlations
between fold expression of Bax and % memory retention at
Fig. 5 Electron
microphotographs of rat
prefrontal cortex stained with
uranyl acetate-lead citrate. a
CON, control; bCON+PA, GSPE
supplemented control; c STZ,
STZ-induced diabetics; d STZ+
PA, GSPE supplemented
diabetics; e STZ+INS, diabetics
treated with insulin; f STZ+INS+
PA, diabetics treated with INS and
GSPE. Arrows indicate normal
mitochondria and short arrow
indicate swollen mitochondria in
neuronal body. X 23000 (Original
magnification)
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week 2 (r =− 0.650) and week 4 (r =− 0.55) are shown in
Figs.S1 (C) and (E) respectively.
The correlation between neuronal survival and pro-and
anti-apoptotic factors is represented in Fig.S2. A positive
relation was seen between the number of surviving neurons
and fold expression of Bcl-2 (r = +0.703) while neuronal
survival correlated negatively with BAX (r = − 0.762).
Discussion
In our study, GSPE and insulin, both singly, and com-
bined were tested in vivo to evaluate their role in the
progression in the cognitive decline of diabetic rats. The
observed results on body weight loss accompanied by
elevated glucose levels and glucose tolerance in the dia-
betic rats, despite increased food intake, may be a conse-
quence of depleted glucose levels in the organs resulting
from reduced insulin synthesis (Moussa 2008) and an el-
evated catabolism of carbohydrates (Novikova et al. 2013;
King 2012; Reyes et al. 2006). GSPE alone when admin-
istered orally was effective in reducing FBS, PPBS and
glucose tolerance levels and also resulted in an
improvement in body weight as much as an insulin
treatment. Our result on high glucose tolerance in the
diabetic rats is concomitant with lowered plasma insulin
and pancreatic immunoreactive insulin. Interestingly, a
combination of GSPE and insulin significantly altered
the above parameters, while insulin and GSPE alone
altered to a lesser extent. Zhen et al. (2014) have shown
proanthocyanidins as natural antioxidants with insulin mi-
metic action. On the contrary, Al-Awwadi et al. (2004)
have reported no impact of polyphenolic extracts on
Fig. 7 Immunohistochemical
reactivity of insulin secreting ß-
cells in the pancreas. a CON,
control; b CON+PA, GSPE
supplemented control; c STZ,
STZ-induced diabetics; d STZ+
PA, GSPE supplemented
diabetics; e STZ+INS, diabetics
treated with insulin; f STZ+INS+
PA, diabetics treated with INS and
GSPE.
Fig. 6 Neuronal survival in the rat prefrontal cortex as a function of
GSPE supplementation and insulin treatment in diabetic rats. Values are
mean ± SEM (n = 3 rats/group). Significance was tested by Tukey’s
Multiple Comparison Test and is represented in lower case. Groups
sharing different letters are significant (p < 0.05)
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plasma insulin levels in STZ-induced diabetic rats. Our results
on restoration of normal glucose levels due to GSPE may be
related to lesser destruction of β-cells in the diabetic rats and is
in accordance with findings reported by Kao (2009) and El-
Alfy et al. 2005. In STZ-induced T1DM, DNA alkylation is
the primary source of β-cell destruction apart from the in-
creased effects of reactive oxygen species on the pancreas
(Lenzen 2008). The present result on the improved number
of β-cells in diabetic animals treated with combined insulin
and GSPE can be related to earlier reports on cell regeneration
following immediate treatment with insulin for hyperglycemia
(Thulesen et al. 1997) and of GSPs on restoration of normal
architecture of beta cells (El-Alfy et al. (2005).
The present study, ultrastructurally demonstrates a reduced
number of insulin secretory granules in the β- cell along with
disrupted and vacuolated mitochondria in diabetic rats. GSPE
supplementation as an adjunct therapy with a daily low dose
of insulin treatment was effective in reversing these changes.
Further, our observations on increased Nissl-positive neurons
with condensed cytoplasm and pyknotic nuclei in the PFC of
diabetic rats is suggestive of apoptotic cells (Hernández-
Fonseca et al. 2009) causing a decline in the cognitive ability
in STZ-induced diabetes (Artola 2008). The present findings
on the gluoconeurotoxicity induced by STZ in the neurons of
PFC are comparable to the earlier findings of Tomlinson and
Gardiner (2008) on hyperglycemic-induced neurotoxicity in
Fig. 8 Quantification of
immunoreactivity of insulin in the
pancreas. The optical density was
analyzed, and the results are
shown in the bar graphs (a).
Plasma fasting insulin levels (b)
and postprandial insulin levels(c).
Values are mean ± SEM (n = 3
rats/group). Significance was
tested by Tukey’s Multiple
Comparison Test and is
represented in lower case. Groups
sharing different letters are
significant (p < 0.05)
Fig. 9 a Amplification of
antiapoptotic (Bcl-2), b apoptotic
(Bax) and c housekeeping gene
(β-actin) expression in the
prefrontal cortex. (1), CON; (2),
CON+PA, control supplemented
with GSPE; (3), STZ, STZ-
induced diabetics; (4), STZ+PA;
GSPE supplemented diabetics;
(5), STZ+INS, diabetics treated
with insulin; (6), STZ+INS+PA,
diabetics treated with INS and
GSPE.
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rats subjected to STZ. Significant recovery in the insulin and
GSPE treated diabetics is comparable to the report on allevi-
ated stress with environmental enrichment exposures in STZ-
treated diabetic rats (Pamidi and Nayak 2014) and of GSPE in
protecting pyramidal neurons of the cerebral cortex in STZ-
induced diabetes through modulation of advanced glycation
end products and NF-kβ p65(Lu et al. 2010).
Animal models of T1DM show different extents of spa-
tial learning and memory loss (Popovic et al. 2001) with
the involvement of the cortex and hippocampus (Parihar
et al. 2004). In this study, the learning and memory abilities
of diabetic rats were evaluated by a T-maze test that is
suitable for exploratory and spatial cognition assessments
(Masso et al. 2017). Our data indicates that T1DM rats
develop working memory and learning deficiencies that
areconsistent with previous reports on behavior test in a
Y-maze (Mirshekar et al. 2011). Interestingly, our results
show that insulin treatment and GSPE supplementation
improves acquisition and retention in STZ-treated diabetic
animals compared to non-diabetic controls. These findings
suggest a decrease in Bax with concomitant increases in
Bcl-2 levels in the PFC.
In summary, our experimental evidence on animal studies
indicates a role of GSPE, a natural product, as an adjunct form
of therapy with a low insulin dose to alleviate the over expres-
sion of apoptotic proteins and the prevention of cognitive
declines in T1DM rats. Studies on adult diabetic animals,
suggest that GSPE is a possible adjunct therapy to be used
along with insulin to alleviate mild cognitive declines in adult
human subjects that progress with cognitive impairment in the
later years of life.
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